On the stock market since 1996, it operates in the world of health and science. It has 19 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 9% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $274K would still be left in the vault — a solid cushion for hard times.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
An investor who bought at the very peak is down 61% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 3 years, sales grew about 11% a year on average.
There is $413K in the vault; even if every debt were paid off, $274K would remain.
The stock sits at $0.25. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
The company’s market value is 60 times its annual profit. Even a small disappointment could hit the price hard.
On our five-subject report card, PCYN sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: PCYN is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.